Medicare Enrolled

Dr. Enrique Perez, MD

Hematology & Oncology · Carrollton, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4325 N JOSEY LN, Carrollton, TX 75010
9723944368
In practice since 2006 (19 years)
NPI: 1437108081 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Perez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Perez

Dr. Enrique Perez is a hematology & oncology in Carrollton, TX, with 19 years in practice. Based on federal Medicare data, Dr. Perez performed 16,540 Medicare services across 1,883 unique beneficiaries.

Between the years covered by Open Payments, Dr. Perez received a total of $4,952 from 54 pharmaceutical and/or device companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Perez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 34% volume in TX$ $4,952 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,540
Medicare services
Top 34% in TX for hematology & oncology
1,883
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~871 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Pembrolizumab injection (Keytruda)6,900$43$137
Anti-nausea injection (fosaprepitant)4,050$0$5
Blood draw (venipuncture)752$8$20
Complete blood count (CBC) with differential598$8$36
Comprehensive metabolic blood panel486$10$64
Magnesium level test434$7$29
Dexamethasone injection (steroid)434$0$1
Phosphate level test431$5$24
Office visit, established patient (20-29 min)389$59$250
Anti-nausea injection (Aloxi/palonosetron)330$1$114
Office visit, established patient (30-39 min)165$94$368
Ferritin level test (iron stores)130$13$60
Iron level test130$6$27
Iron binding capacity test130$9$35
Administration of chemotherapy into vein, 1 hour or less103$97$707
Injection of additional new drug or substance into vein97$12$108
Microscopic examination for white blood cells with manual cell count85$4$22
Complete blood count (CBC), automated84$6$34
Drug injection, under skin or into muscle83$10$96
Injection, zoledronic acid, 1 mg72$6$431
Lactate dehydrogenase (enzyme) level66$6$31
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less56$47$313
Infusion, normal saline solution , 1000 cc53$2$19
Vitamin B-12 level test49$15$76
Folic acid level test49$14$73
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less37$22$157
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries37$91$657
Thyroid stimulating hormone (TSH) test35$16$80
Infusion into a vein for hydration, 31-60 minutes35$25$256
Reticulated (young) platelet measurement34$35$143
Nuclear medicine study from skull base to mid-thigh with ct scan32$1,109$4,802
Administration of chemotherapy into vein, each additional hour31$21$161
Infusion into a vein for hydration, each additional hour29$10$75
Injection, diphenhydramine hcl, up to 50 mg29$1$7
Administration of additional new drug or substance into vein, 1 hour or less25$49$344
Office visit, established patient (10-19 min)24$29$150
New patient office visit (45-59 min)19$116$565
Office visit, established patient, complex (40-54 min)17$126$496
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
73.5% medium
25.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,952
Total received (2018-2024)
Avg $707/year across 7 years
Top 43% in TX for hematology & oncology
54
Companies
196
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,037 (81.5%)
Other
Charitable contributions, space rental, and other categories
$608 (12.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$307 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,644
2023
$995
2022
$788
2021
$32
2020
$261
2019
$640
2018
$593

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$825
AstraZeneca Pharmaceuticals LP
$270
Amgen Inc.
$261
Celgene Corporation
$247
Genentech USA, Inc.
$205
Merck Sharp & Dohme Corporation
$197
Astellas Pharma US Inc
$185
E.R. Squibb & Sons, L.L.C.
$176
PFIZER INC.
$174
Merck Sharp & Dohme LLC
$157
Takeda Pharmaceuticals U.S.A., Inc.
$150
Gilead Sciences, Inc.
$116
ABBVIE INC.
$109
Bayer Healthcare Pharmaceuticals Inc.
$108
EISAI INC.
$102
Incyte Corporation
$98
Blueprint Medicines Corporation
$86
Seagen Inc.
$83
Karyopharm Therapeutics Inc.
$78
Mirati Therapeutics, Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
GENZYME CORPORATION
$68
Ipsen Biopharmaceuticals, Inc
$67
TAIHO ONCOLOGY, INC.
$63
Lilly USA, LLC
$61
Kite Pharma, Inc.
$59
SOBI, INC
$58
Adaptive Biotechnologies Corporation
$57
JAZZ PHARMACEUTICALS INC.
$52
PharmaEssentia USA Corporation
$48
Apellis Pharmaceuticals, Inc.
$48
Eisai Inc.
$48
Dendreon Pharmaceuticals LLC
$46
Janssen Biotech, Inc.
$43
TESARO, Inc.
$37
Pharmacyclics LLC, An AbbVie Company
$34
EMD Serono, Inc.
$33
ARRAY BIOPHARMA INC
$32
ADC Therapeutics America, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$27
Advanced Accelerator Applications
$26
Exelixis Inc.
$26
TerSera Therapeutics LLC
$25
CTI BioPharma Corp.
$25
Stemline Therapeutics Inc.
$20
GlaxoSmithKline, LLC.
$20
Immunocore Limited
$19
Medtronic USA, Inc.
$19
Rigel Pharmaceuticals, Inc.
$17
Taiho Oncology, Inc.
$17
Sun Pharmaceutical Industries Inc.
$17
Kyowa Kirin, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Clovis Oncology, Inc.
$13
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Alecensa · Avastin · BESREMI · BOSULIF · BRAFTOVI · CABOMETYX · CALQUENCE · CARVYKTI · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EPKINLY · Empaveli · GILOTRIF · IBRANCE · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · NINLARO · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Phesgo · Polivy · Pomalyst · REBLOZYL · RYDAPT · Revlimid · Rubraca · SOMATULINE DEPOT · SPRYCEL · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tazverik · Trodelvy · VERZENIO · VOTRIENT · Venclexta · Vonjo · XPOVIO · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $30 per 100 Medicare services performed
Looking for a hematology & oncology in Carrollton?
Compare hematology & oncologys in the Carrollton area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
133
Per 100K population
14.1
County median income
$108,185
Nearest hospital
CARROLLTON REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Perez is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Perez experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Perez performed 6,900 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perez receive payments from pharmaceutical companies?
Yes. Dr. Perez received a total of $4,952 from 54 companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perez's costs compare to other hematology & oncologys in Carrollton?
Dr. Perez's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →